Lise-Lotte Guldmann

Lise-Lotte Guldmann is a seasoned professional in the pharmaceutical industry, currently serving as Director of the Quality Unit and Regulatory and Clinical Affairs at Fertin Pharma A/S since October 2019. Previously, Lise-Lotte held various leadership roles at Novo Nordisk from February 2002 to June 2019, including Director of Internal Audits, ensuring global quality compliance in 80 countries, and Director of QA for insulin manufacturing operations. Lise-Lotte's expertise encompasses quality assurance, regulatory affairs, and project management within complex manufacturing environments producing critical diabetes and obesity treatments. Academic credentials include a Ph.D. in Biochemistry and Molecular Biology and a Master of Science in Biology from Aarhus University, alongside a period of post-doctoral research at the John Innes Centre.